- Home
- PCB vs TARA Comparison
PCB vs TARA Comparison
Compare PCB & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PCB | TARA |
|---|---|---|
| Founded | 2003 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 351.0M | 292.9M |
| IPO Year | 2018 | 2014 |
Fundamental Metrics
Financial Performance| Metric | PCB | TARA |
|---|---|---|
| Price | $23.38 | $5.16 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $25.50 | $24.40 |
| AVG Volume (30 Days) | 17.9K | ★ 606.9K |
| Earning Date | 04-23-2026 | 05-01-2026 |
| Dividend Yield | ★ 3.65% | N/A |
| EPS Growth | ★ 48.28 | 38.25 |
| EPS | ★ 0.74 | N/A |
| Revenue | $2,899,000.00 | ★ $2,948,000.00 |
| Revenue This Year | $13.73 | N/A |
| Revenue Next Year | $9.07 | N/A |
| P/E Ratio | $31.65 | ★ N/A |
| Revenue Growth | ★ 4.51 | N/A |
| 52 Week Low | $19.28 | $2.77 |
| 52 Week High | $25.15 | $7.82 |
Technical Indicators
Market Signals| Indicator | PCB | TARA |
|---|---|---|
| Relative Strength Index (RSI) | 43.48 | 46.20 |
| Support Level | $21.12 | $4.92 |
| Resistance Level | $24.25 | $5.53 |
| Average True Range (ATR) | 0.50 | 0.27 |
| MACD | -0.17 | -0.01 |
| Stochastic Oscillator | 7.85 | 29.25 |
Price Performance
Historical ComparisonAbout PCB PCB Bancorp
PCB Bancorp is a bank holding company, which engages in the provision of consumer and commercial banking services. It provides Personal, Business, and Loan services, which provide banking, lending, and digital, tools, home loans, and others. Also, it offers a broad range of loans, deposits, and other products and services predominantly to small and middle-market businesses and individuals. The company provided it's services in Los Angeles and Orange Counties, California; Bellevue, Washington; and Atlanta, Georgia.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.